The Company has entered into a non-binding term sheet in relation to a corporate transaction to acquire
a company with a late-stage (Phase 2) asset in the chemotherapeutics sector (Term Sheet). The Term
Sheet provides for the parties to provide each other with a 90-day exclusivity period to conduct due
diligence and negotiate formal agreements in respect of the transaction.
all things going well maybe by end of Feb
Ann: Company Update, page-29
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add FL1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.15M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.0¢ | 13.0¢ | $9.459K | 70.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24282 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 4147 | 1 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| FL1 (ASX) Chart |